List of NeuroGenetic Pharmaceuticals patents | 5 results

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7781442 Compounds and uses thereof in modulating amyloid beta	Patent 7781442 was granted and assigned to NeuroGenetic Pharmaceuticals on August, 2010 by the United States Patent and Trademark Office.	NeuroGenetic Pharmaceuticals	United States Patent and Trademark Office	7781442	August 24, 2010
‌ US Patent 8119680 α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom	Patent 8119680 was granted and assigned to NeuroGenetic Pharmaceuticals on February, 2012 by the United States Patent and Trademark Office.	NeuroGenetic Pharmaceuticals	United States Patent and Trademark Office	8119680	February 21, 2012
‌ US Patent 7799808 α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom	Patent 7799808 was granted and assigned to NeuroGenetic Pharmaceuticals on September, 2010 by the United States Patent and Trademark Office.	NeuroGenetic Pharmaceuticals	United States Patent and Trademark Office	7799808	September 21, 2010
‌ US Patent 8017629 Compounds and uses thereof in modulating amyloid β	Patent 8017629 was granted and assigned to NeuroGenetic Pharmaceuticals on September, 2011 by the United States Patent and Trademark Office.	NeuroGenetic Pharmaceuticals	United States Patent and Trademark Office	8017629	September 13, 2011
‌ US Patent 8871460 Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor	Patent 8871460 was granted and assigned to NeuroGenetic Pharmaceuticals on October, 2014 by the United States Patent and Trademark Office.	NeuroGenetic Pharmaceuticals	United States Patent and Trademark Office	8871460	October 28, 2014